Susan Graf

Chairman at FINCH THERAPEUTICS GROUP, INC.

Net worth: 374 $ as of 2024-04-29

52 year

84 connections

Health Technology

Consumer Services

Health Services

Active connections

Name	Gender	Age	Linked companies	Collaboration
Ronald D. Gunn	M	63	Kaleo, Inc. Kaleo, Inc. Pharmaceuticals: MajorHealth Technology Kaleo, Inc. develops drug/device combination products. Its products empower patients to gain freedom from their medical condition. The firm's capabilities include drug development, device development, regulatory and clinical, manufacturing, commercialization and data generation. The company was founded by Eric S. Edwards and Evan T. Edwards in 2005 and is headquartered in Richmond, VA.	-
Arthur Kuan	M	34	CG ONCOLOGY, INC.	7 years
Chris Shumway	M	58	FINCH THERAPEUTICS GROUP, INC.	4 years
Elder Granger	M	70	Kaleo, Inc. Kaleo, Inc. Pharmaceuticals: MajorHealth Technology Kaleo, Inc. develops drug/device combination products. Its products empower patients to gain freedom from their medical condition. The firm's capabilities include drug development, device development, regulatory and clinical, manufacturing, commercialization and data generation. The company was founded by Eric S. Edwards and Evan T. Edwards in 2005 and is headquartered in Richmond, VA.	2 years
Victor Tong	M	41	CG ONCOLOGY, INC.	1 years
Hong Fang Song	F	59	CG ONCOLOGY, INC.	9 years
Ned Ruffin	M	-	Kaleo, Inc. Kaleo, Inc. Pharmaceuticals: MajorHealth Technology Kaleo, Inc. develops drug/device combination products. Its products empower patients to gain freedom from their medical condition. The firm's capabilities include drug development, device development, regulatory and clinical, manufacturing, commercialization and data generation. The company was founded by Eric S. Edwards and Evan T. Edwards in 2005 and is headquartered in Richmond, VA.	-
Jeffery Smisek	M	69	FINCH THERAPEUTICS GROUP, INC.	7 years
James Mulé	M	72	CG ONCOLOGY, INC.	6 years
Ambaw Bellete	M	54	CG ONCOLOGY, INC.	1 years
Christian Lange	M	44	FINCH THERAPEUTICS GROUP, INC.	7 years
Michael Wells	M	55	Kaleo, Inc. Kaleo, Inc. Pharmaceuticals: MajorHealth Technology Kaleo, Inc. develops drug/device combination products. Its products empower patients to gain freedom from their medical condition. The firm's capabilities include drug development, device development, regulatory and clinical, manufacturing, commercialization and data generation. The company was founded by Eric S. Edwards and Evan T. Edwards in 2005 and is headquartered in Richmond, VA.	-
Domenic Ferrante	M	58	FINCH THERAPEUTICS GROUP, INC.	5 years
Leonard Post	M	72	CG ONCOLOGY, INC.	6 years
Brian Liu	M	36	CG ONCOLOGY, INC.	2 years
Matthew Nelson	M	-	FINCH THERAPEUTICS GROUP, INC.	3 years
Randy Raisman	M	-	Kaleo, Inc. Kaleo, Inc. Pharmaceuticals: MajorHealth Technology Kaleo, Inc. develops drug/device combination products. Its products empower patients to gain freedom from their medical condition. The firm's capabilities include drug development, device development, regulatory and clinical, manufacturing, commercialization and data generation. The company was founded by Eric S. Edwards and Evan T. Edwards in 2005 and is headquartered in Richmond, VA.	-
Jim Lenehan	M	-	Kaleo, Inc. Kaleo, Inc. Pharmaceuticals: MajorHealth Technology Kaleo, Inc. develops drug/device combination products. Its products empower patients to gain freedom from their medical condition. The firm's capabilities include drug development, device development, regulatory and clinical, manufacturing, commercialization and data generation. The company was founded by Eric S. Edwards and Evan T. Edwards in 2005 and is headquartered in Richmond, VA.	-
Matthew Blischak	M	-	FINCH THERAPEUTICS GROUP, INC.	1 years
Vijay Kasturi	M	57	CG ONCOLOGY, INC.	1 years
Lance Thibault	M	58	FINCH THERAPEUTICS GROUP, INC.	1 years
Sonia Timberlake	M	-	FINCH THERAPEUTICS GROUP, INC.	-
Erin Graves	M	-	EPIZYME, INC.	7 years
Michelle L. Rose	M	-	FINCH THERAPEUTICS GROUP, INC.	-
Bing Kung	M	-	CG ONCOLOGY, INC.	-
Evan Bedil	M	-	Kaleo, Inc. Kaleo, Inc. Pharmaceuticals: MajorHealth Technology Kaleo, Inc. develops drug/device combination products. Its products empower patients to gain freedom from their medical condition. The firm's capabilities include drug development, device development, regulatory and clinical, manufacturing, commercialization and data generation. The company was founded by Eric S. Edwards and Evan T. Edwards in 2005 and is headquartered in Richmond, VA.	3 years
Swapnil Bhargava	M	-	CG ONCOLOGY, INC.	1 years

Connections Chart

Multi-company connection

Former connections

Name	Gender	Age	Linked companies	Collaboration
Andrew Singer	M	53	EPIZYME, INC.	2 years
Suzanne Fleming	F	63	EPIZYME, INC.	2 years
Matthew Ros	M	57	EPIZYME, INC.	5 years
Andrew Noh	M	-	FINCH THERAPEUTICS GROUP, INC.	4 years
Mark Smith	M	37	FINCH THERAPEUTICS GROUP, INC.	6 years
Marc Blaustein	M	61	FINCH THERAPEUTICS GROUP, INC.	2 years
Francois Nader	M	67	NPS PHARMACEUTICALS, INC.	7 years
Joseph Vittiglio	M	52	FINCH THERAPEUTICS GROUP, INC.	2 years
Edward H. Stratemeier	M	75	NPS PHARMACEUTICALS, INC.	5 years
Joseph Beaulieu	M	43	EPIZYME, INC.	5 years
Christine Cvijic	F	46	NPS PHARMACEUTICALS, INC.	1 years
Pedro Granadillo	M	77	NPS PHARMACEUTICALS, INC.	5 years
Julie DiCarlo	F	-	EPIZYME, INC.	-
Brendan P. Rae	M	-	NPS PHARMACEUTICALS, INC.	1 years
Zain Kassam	M	42	FINCH THERAPEUTICS GROUP, INC.	4 years
Nicholas Haft	M	35	FINCH THERAPEUTICS GROUP, INC.	3 years
Anne Marie Conway	F	-	FINCH THERAPEUTICS GROUP, INC.	-
Christine Mikail,	-	-	NPS PHARMACEUTICALS, INC.	1 years
Samuel Hamood	M	56	FINCH THERAPEUTICS GROUP, INC.	-
Colin Broom	M	68	NPS PHARMACEUTICALS, INC.	6 years
Roger Garceau	M	70	NPS PHARMACEUTICALS, INC.	7 years
Michael Bonney	M	65	NPS PHARMACEUTICALS, INC.	10 years
Tai Ching Ho	M	62	EPIZYME, INC.	3 years
Kevin Conroy	M	58	EPIZYME, INC.	5 years
Gregory Perry	M	63	FINCH THERAPEUTICS GROUP, INC.	4 years
John F. Weidenbruch	M	63	EPIZYME, INC.	5 years
Shefali Agarwal	M	50	EPIZYME, INC.	4 years
Debra Silberg	M	-	FINCH THERAPEUTICS GROUP, INC.	-
Vishal Kapoor	M	48	NPS PHARMACEUTICALS, INC.	1 years
Andrea Edwards	F	-	EPIZYME, INC.	3 years
Jason Fredette	M	-	EPIZYME, INC.	-
Chris Weidenmaier	M	-	FINCH THERAPEUTICS GROUP, INC.	-
John Bishop	M	62	EPIZYME, INC.	4 years
David Rhodes	M	-	FINCH THERAPEUTICS GROUP, INC.	3 years
Ralf H. Rosskamp	M	71	NPS PHARMACEUTICALS, INC.	2 years
David Pugatch	M	-	FINCH THERAPEUTICS GROUP, INC.	2 years
Robert Copeland	M	-	EPIZYME, INC.	9 years
Bryan Gillis	M	-	FINCH THERAPEUTICS GROUP, INC.	1 years
Zoran Zdraveski	M	54	EPIZYME, INC.	5 years
Eric Pauwels	M	63	NPS PHARMACEUTICALS, INC.	4 years
Marcio Souza	M	45	NPS PHARMACEUTICALS, INC.	2 years
Alka Batycky	M	54	FINCH THERAPEUTICS GROUP, INC.	1 years
Scott Wilhoit	M	61	NPS PHARMACEUTICALS, INC.	2 years
Susan M. Mesco	F	-	NPS PHARMACEUTICALS, INC.	7 years
Pierre Legault	M	63	NPS PHARMACEUTICALS, INC.	1 years
Robin D. Friedman	F	-	NPS PHARMACEUTICALS, INC.	1 years
Kenneth Bahrt	M	71	NPS PHARMACEUTICALS, INC.	1 years
Luke Beshar	M	65	NPS PHARMACEUTICALS, INC.	8 years
Ellen Rosenberg	F	61	NPS PHARMACEUTICALS, INC.	-
Alyssa Wyant	F	49	NPS PHARMACEUTICALS, INC.	3 years
Pamela Strode	F	-	EPIZYME, INC.	3 years
Glenn R. Melrose	M	68	NPS PHARMACEUTICALS, INC.	2 years
Dhiren D'silva	M	-	NPS PHARMACEUTICALS, INC.	2 years
Rebecca Cohen	F	-	EPIZYME, INC.	-
Patrik Florencio	M	-	NPS PHARMACEUTICALS, INC.	1 years
Paul Firuta	M	58	NPS PHARMACEUTICALS, INC.	1 years
Leah Neufeld	F	51	NPS PHARMACEUTICALS, INC.	1 years

Statistics

Country	Connections	% of total
United States	84	100.00%

Age of Connections

Active

Past

Male

Female

Members of the board

Executives

Origin of connections